Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Reitamo

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
The British Journal of Dermatology|March 20, 2004
0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trialS Reitamo, J Harper, J D Bos, et al.
The British Journal of Dermatology|June 14, 2005
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitisS Reitamo, J P Ortonne, C Sand, et al.
The New England Journal of Medicine|September 19, 1997
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study GroupT Ruzicka, T Bieber, E Schöpf, et al.
Archives of Dermatology|August 5, 2000
Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study GroupS Reitamo, A Wollenberg, E Schöpf, et al.
The British Journal of Dermatology|July 22, 2008
A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patientsS Reitamo, M Rustin, J Harper, et al.
Allergy|November 3, 2010
The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled studyR Foelster Holst, S Reitamo, R Yankova, et al.
The British Journal of Dermatology|June 14, 2005
Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trialK Wolff, C Fleming, J Hanifin, et al.
The British Journal of Dermatology|September 1, 1999
Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study GroupV C Ho, C E Griffiths, G Albrecht, et al.
The British Journal of Dermatology|September 11, 2008
Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative studyD Thaçi, S Reitamo, M A Gonzalez Ensenat, et al.
The British Journal of Dermatology|April 12, 2001
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitisT Luger, E J Van Leent, M Graeber, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
The British Journal of Dermatology|March 20, 2004
0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trialS Reitamo, J Harper, J D Bos, et al.
The British Journal of Dermatology|June 14, 2005
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitisS Reitamo, J P Ortonne, C Sand, et al.
The New England Journal of Medicine|September 19, 1997
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study GroupT Ruzicka, T Bieber, E Schöpf, et al.
Archives of Dermatology|August 5, 2000
Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study GroupS Reitamo, A Wollenberg, E Schöpf, et al.
The British Journal of Dermatology|July 22, 2008
A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patientsS Reitamo, M Rustin, J Harper, et al.
Allergy|November 3, 2010
The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled studyR Foelster Holst, S Reitamo, R Yankova, et al.
The British Journal of Dermatology|June 14, 2005
Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trialK Wolff, C Fleming, J Hanifin, et al.
The British Journal of Dermatology|September 1, 1999
Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study GroupV C Ho, C E Griffiths, G Albrecht, et al.
The British Journal of Dermatology|September 11, 2008
Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative studyD Thaçi, S Reitamo, M A Gonzalez Ensenat, et al.
The British Journal of Dermatology|April 12, 2001
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitisT Luger, E J Van Leent, M Graeber, et al.
Pageof 14